Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations

被引:0
作者
Amy Østertun Geirdal
Jon G. Reichelt
Alv A. Dahl
Ketil Heimdal
Lovise Mæhle
Astrid Stormorken
Pål Møller
机构
[1] The Norwegian Radium Hospital,Section for Genetic Counselling, Department of Cancer Genetics
[2] Aker University Hospital,Department of Psychiatry
来源
Familial Cancer | 2005年 / 4卷
关键词
anxiety; depression; familial breast and ovarian cancer; familial colon cancer; psychological distress;
D O I
暂无
中图分类号
学科分类号
摘要
Aim: To examine psychological distress in women at risk of familial breast–ovarian cancer (FBOC) or hereditary non-polyposis colorectal cancer (HNPCC) with absence of demonstrated mutations in the family (unknown mutation).Materials and methods: Two-hundred and fifty three consecutive women at risk of FBOC and 77 at risk of HNPCC and with no present or past history of cancer. They were aware of their risk and had received genetic counseling. Comparisons were made between these two groups, normal controls, and women who were identified to be BRCA1 mutation carriers. The questionnaires Beck Hopelessness Scale (BHS), General Health Questionnaire (GHQ-28), Hospital Anxiety and Depression Scale (HADS) and Impact of Event Scale (IES) were employed to assess psychological distress.Results: No significant differences concerning psychological distress were observed between women with FBOC and women with HNPCC. Compared to mutation carriers for BRCA1, the level of anxiety and depression was significantly higher in the FBOC group with absence of demonstrated mutation. Compared to normal controls, the level of anxiety was higher, while the level of depression was lower in the groups with unknown mutation.Conclusions: Women in the absence of demonstrated mutations have higher anxiety and depression levels than women with known mutation-carrier status. Access to genetic testing may be of psychologically benefit to women at risk for FBOC or HNPCC.
引用
收藏
页码:121 / 126
页数:5
相关论文
共 96 条
  • [1] Moller P(2002)Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy Int J Cancer 101 555-9
  • [2] Borg A(2003)Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene Am J Hum Genet 72 1088-100
  • [3] Evans DG(2001)Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study Int J Cancer 93 608-11
  • [4] Wagner A(2002)Psychological impact of genetic testing in women from high-risk breast cancer families Eur J Cancer 38 2025-31
  • [5] Barrows A(1996)BRCA1 testing in families with hereditary breast–ovarian cancer. A prospective study of patient decision making and outcomes JAMA 275 1885-92
  • [6] Wijnen JT(1998)What you don’t know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing J Clin Oncol 16 1650-4
  • [7] Aktan-Collan K(2001)Psychological impact of receiving a BRCA1/BRCA2 test result Am J Med Genet 98 15-24
  • [8] Haukkala A(1997)Psychological responses to BRCA1 mutation testing: preliminary findings Health Psychol 16 63-72
  • [9] Mecklin JP(1999)The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer Br J Cancer 79 868-74
  • [10] Meiser B(1999)The impact of genetic counselling about breast cancer risk on women’s risk perceptions and levels of distress Br J Cancer 79 501-8